NCT02605057View on ClinicalTrials.gov

Dermatopharmacokinetic Trial of LEO 80185 Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 80185 gel

DRUG

Dovobet(r) Ointment

Trial Locations (1)

160-0017

Shinanokai Shinanozaka Clinic, Tokyo

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT02605057 - Dermatopharmacokinetic Trial of LEO 80185 Gel | Biotech Hunter | Biotech Hunter